Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders
Author:
Affiliation:
1. Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, 221005, India
Abstract
Publisher
Future Medicine Ltd
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2021-0389
Reference87 articles.
1. Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges
2. Advanced nanomedicines for the treatment of inflammatory diseases
3. Drug delivery to the lungs: challenges and opportunities
4. Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy
5. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hybrid liposomes of DPPC/cholesterol/octyl-β-D-glucopyranoside with/without ibuprofen: thermal and morphological study;Journal of Thermal Analysis and Calorimetry;2023-11-06
2. In vitro bio-characterization of solid lipid nanoparticles of favipiravir in A549 human lung epithelial cancer cells;Journal of Taibah University Medical Sciences;2023-10
3. Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system;Nano Today;2023-10
4. Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments;Pharmaceutics;2022-12-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3